Is leucoreduced red cell transfusion have advantage over non-leucoreduced red cell transfusion in patients of pediatric cardiac surgery?
Phase 4
- Conditions
- Health Condition 1: null- Ventricular Septal defect and tetrology of fellotpatients undergoing cardiac surgery
- Registration Number
- CTRI/2017/07/008972
- Lead Sponsor
- Postgraduate Institute of Medical Education and Research Chandigarh
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 90
Inclusion Criteria
patients (upto 10 years of age) undergoing cardiac surgery for congenital heart disease, who had not received blood transfusion within the last 3 months.
Exclusion Criteria
Patients who have received blood transfusion in last three months and patients with Rh (D) negative blood group.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method MortalityTimepoint: 90 days
- Secondary Outcome Measures
Name Time Method In Hospital MortalityTimepoint: 30 days;Intensive care unit stayTimepoint: --;Post-op development of Multiple organ <br/ ><br>dysfunction syndromeTimepoint: 30 days;Post-operative infectionsTimepoint: 30 days;Total hospital stayTimepoint: --